We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $35.13 · 11 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Alto Neuroscience (ANRO) director awarded 26,000 stock options at $20.44 strike price - Stock Titan
Alto Neuroscience (ANRO) director awarded 26,000 stock options at $20.44 strike price Stock Titan
Alto Neuroscience (ANRO) director Andrew Craig Miller files initial Form 3 - Stock Titan
Alto Neuroscience (ANRO) director Andrew Craig Miller files initial Form 3 Stock Titan
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller to Board of Directors - geneonline.com
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller to Board of Directors geneonline.com
Alto Neuroscience, Inc. (ANRO) Files 8-K Report Announcing No Soliciting Material or Tender Offers – Company Info & NYSE Listing - Minichart
Alto Neuroscience, Inc. (ANRO) Files 8-K Report Announcing No Soliciting Material or Tender Offers – Company Info & NYSE Listing Minichart
H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
H.C. Wainwright Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Maintains Target Price $50 富途牛牛
Alto Neuroscience Adds Karuna Therapeutics Founder Andrew Miller to Board of Directors - citybiz
Alto Neuroscience Adds Karuna Therapeutics Founder Andrew Miller to Board of Directors citybiz
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 12. | After market close (AMC) | $-0.77 | — | — | $0 | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 19. | Baird | — | Maintain | Outperform → Outperform | — | Baird: Outperform |
| 2026. 05. 14. | Wedbush | — | Maintain | Neutral → Neutral | — | Wedbush: Neutral |
| 2026. 05. 12. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 04. 23. | Chardan Capital | — | Maintain | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 04. 03. | Baird | — | Maintain | Outperform → Outperform | — | Baird: Outperform |
| 2026. 04. 03. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 1,606,954 | $28.6B | 0.05% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 503,087 | $11.31B | 0.02% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 216,099 | $4.86B | 0.00% | — | New position |
| 4 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 140,317 | $2.5B | 0.00% | — | New position |